Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00533
Species: Homo sapiens
Position : chr12:120729447-120730585
Year: 2020
Title: Noncoding Variants Connect Enhancer Dysregulation with Nuclear Receptor Signaling in Hematopoietic Malignancies.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: hematopoietic malignancy
PMID:  32188707
Tissue: bone marrow
Tissue Ontology ID: UBERON:0002371
Cell Source: MKPL-1
CVCL ID: CVCL_2116
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: High-throughput functional CRE perturbation screen; candidate enhancer annotation; Disease-variant functional analysis
High Throughput Method: pooled enCRISPRi screen; pooled enCRISPRa screen; H3K27ac ChIP-seq; ATAC-seq
Low Throughput Method: individual CRISPRi; CRISPR-Cas57 TF-binding-site deletion
About Target Gene
Target gene : SIRT4
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 2 found
Enhancer ID Position Tissue Cell Disease
E_00534 chr12:120729447-120730585 bone marrow malignant cell hematopoietic malignancy
E_00664 chr12:120729447-120730585 blood NA hematologic malignancy
Expression of Target Genes for the Enhancer